Terapin
PrivateLast Round
Private Equity
Aug 1, 2022
Est. Valuation
$58.62M
Total Funding Raised
$167.66M
Company Overview
Terapin is a digital content company that specializes in the production, distribution, and monetization of webtoons, web novels, and character intellectual property.
Sector
Media, Entertainment & Gaming
Verticals
Content Creation, Digital Publishing, Streaming Platforms, Creator Economy
Business Model
B2C
Customer Profile
Subscription SaaS, Revenue Share, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Terapin Comparables
Compare Terapin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TOPCO CO., LTD. | 82% | |
| SK Telecom | 79% | |
| Kakao Corp. | 78% |
Terapin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Aug 1, 2022 | ||||
| Private Equity | Jan 14, 2022 | ||||
| VC Round | Sep 14, 2021 | ||||
| Series B | Apr 21, 2021 | ||||
| Series A Extension | Jun 21, 2020 | ||||
Series A | Nov 13, 2019 |
Terapin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DA Value Investment | Series A Extension, Series A |
| Hyundai Investment Partners | Series B, Series A Extension, Series A |
| KB Investment | Series B, Series A Extension, Series A |
| Wonik Investment Partners | Series B, Series A Extension |
| Affirma Capital | Private Equity |
| NPX Capital | Private Equity, VC Round |
| Daekyo Investment | Series B, Series A Extension, Series A, Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2022
$93M round with Affirma Capital and NPX Capital.
- Jan 14, 2022
$55M round led by NPX Capital.
Terapin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Terapin's valuation, stock price, and market status.
Is Terapin a public or private company?
Terapin is a private company.
What is the current stock price of Terapin?
Terapin is a private company with no public stock price. No recent secondary market data is available.
How much is Terapin worth (valuation)?
Terapin's valuation is estimated at $58.6M based on funding round data.
Can I buy Terapin stock?
Terapin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Terapin's last funding round?
Terapin's most recent funding round was Private Equity on April 21, 2021.
Who are the main investors in Terapin?
Key investors in Terapin include NPX Capital, NPX Capital.
Will Terapin IPO soon?
No public IPO plans have been announced for Terapin.
How can I track Terapin secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Terapin's secondary market activity and sign up for updates.